Literature DB >> 31420631

[Cerebral hyper perfusion syndrome after carotid artery stenting].

Z C Jia1, H J Bian2, J T Han1, H Y Zhao3, J Y Luan1, C M Wang1, X Li1.   

Abstract

OBJECTIVE: To explore the risk factors, clinical characteristics, precaution and treatment of hyper perfusion syndrome (HPS) after carotid artery stenting (CAS).
METHODS: From September 2014 to March 2018, the clinical data of 226 patients with severe carotid stenosis (70%-99%) treated with carotid artery stenting (CAS)at Department of Interventional Radiology and Vascular Surgery, Peking University Third Hospital, were analyzed retrospectively.Five of them developed HPS after CAS.The relationship between the clinical baseline data, imaging characteristics, perioperative management and HPS were assessed.
RESULTS: In this group, 5 patients of them (2.21%, 5/226) developed HPS after CAS, and 2 patients of them (0.88%, 2/226) were hyper perfusion induced intracranial hemorrhage (HICH). The 5 patients consisted of 4 men and 1 woman whose age ranged from 58 to 74 years. The symptoms of HPS occurred within 4 hours to 3 days after CAS. Among the 5 cases, the clinical manifestations were that 2 cases with headache, 1 case with delirium,1 case with hemiparesis of left limbs, and 1 case with coma(died ultimately).The main manifestations of case 1 and case 2 were headache in the frontal parietal temporal region of the operative side, accompanied by nausea and vomiting. The symptoms were relieved after blood pressure lowering treatment and mannitol dehydration. The main manifestations of case 3 were excitement and delirium. The symptoms were relieved by a small dose of sedatives, also with blood pressure lowering treatment and mannitol dehydration. The initial symptoms of case 4 were excitement and delirium, accompanied by mild headache of the operative side, and hemiplegia of the contralateral limb occurred within a short time. The main manifestation of case 5 was severe headache and went into deep coma within a short time. This patient died of massive cerebral hemorrhage ultimately.
CONCLUSION: HPS is an uncommon but serious complication after CAS. Improving our understanding and heightening vigilance of HPS is necessary. The earlier diagnosis, the earlier treatment.

Entities:  

Mesh:

Year:  2019        PMID: 31420631      PMCID: PMC7433495          DOI: 10.19723/j.issn.1671-167X.2019.04.024

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  10 in total

1.  Carotid stenosis, baroreceptor sensitivity and cerebral autoregulation – implication for cerebral hyperperfusion syndrome –.

Authors:  Kazuo Kitagawa
Journal:  Circ J       Date:  2010-09-11       Impact factor: 2.993

2.  North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress.

Authors: 
Journal:  Stroke       Date:  1991-06       Impact factor: 7.914

3.  [Cerebral hyperperfusion syndrome and blood pressure control].

Authors:  Gábor Fazekas; Gábor Kasza; Endre Arató; László Sínay; Gergely Vadász; Árpád Füzi; Péter Hardi; László Benkő; Tibor Nagy; Gábor Jancsó; Gábor Menyhei
Journal:  Orv Hetil       Date:  2015-06-28       Impact factor: 0.540

Review 4.  Hypertension and the post-carotid endarterectomy cerebral hyperperfusion syndrome.

Authors:  S Bouri; A Thapar; J Shalhoub; G Jayasooriya; A Fernando; I J Franklin; A H Davies
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-12-04       Impact factor: 7.069

5.  Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients.

Authors:  Kuniaki Ogasawara; Nobuyuki Sakai; Terumasa Kuroiwa; Kohkichi Hosoda; Koji Iihara; Kazunori Toyoda; Chiaki Sakai; Izumi Nagata; Akira Ogawa
Journal:  J Neurosurg       Date:  2007-12       Impact factor: 5.115

6.  Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.

Authors:  Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Kenichi Sato; Takashi Inoue; Hiroaki Shimizu; Teiji Tominaga
Journal:  Neurol Res       Date:  2014-08-01       Impact factor: 2.448

Review 7.  The role of neuroeffector mechanisms in cerebral hyperperfusion syndromes.

Authors:  R Macfarlane; M A Moskowitz; D E Sakas; E Tasdemiroglu; E P Wei; H A Kontos
Journal:  J Neurosurg       Date:  1991-12       Impact factor: 5.115

8.  Two-Stage Cerebral Hemodynamic Changes in Staged Carotid Angioplasty and Stenting.

Authors:  Fei Wu; Lei Huang; Gang Lu; Liang Ge; Xiaolong Zhang; Wenjie Cao; Qiang Dong
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-08-17       Impact factor: 2.136

Review 9.  Hyperperfusion syndrome after carotid revascularization.

Authors:  Konstantinos G Moulakakis; Spyridon N Mylonas; Giorgos S Sfyroeras; Vasilios Andrikopoulos
Journal:  J Vasc Surg       Date:  2009-02-26       Impact factor: 4.268

10.  Staged carotid artery angioplasty and stenting for patients with high-grade carotid stenosis with high risk of developing hyperperfusion injury: a retrospective analysis of 44 cases.

Authors:  Dapeng Mo; Gang Luo; Bo Wang; Ning Ma; Feng Gao; Xuan Sun; Xiaotong Xu; Zhongrong Miao
Journal:  Stroke Vasc Neurol       Date:  2016-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.